Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ABSORB: Final Outcomes With the Absorb Bioresorbable Vascular Scaffold
Author(s): David Power Added: 5 months ago
Outcomes investigating the Absorb bioresorbable vascular scaffold (BVS) in patients undergoing percutaneous coronary intervention showed more adverse ischaemic events through 5 years compared with cobalt-chromium everolimus-eluting stents. However, the period of excess risk ended at 3 years.In this short interview, Dr David Power (Mount Sinai Hospital, New York, US) discusses the final report… View more

Vascular Disease and Surgery

Prevention & Chronic Conditions
CRT 24: The ABSORB Trial
Author(s): David Power Added: 1 year ago
CRT 24 - We are joined in this short virtual interview by investigator, Dr David Power (Mount Sinai Hospital, US) to discuss the latest findings from the ABSORB trial series, revealed in 2024 at the CRT conference.ABSORB III is a prospective, randomized, single-blind, multicenter trail aiming to support the pre-market approval of the Absorb bioresorbable vascular scaffold (Abbott) for the… View more

Intervention

Vascular Disease and Surgery
The MOTIV Trial: 3-Year Results
Author(s): Added: 2 months ago
Three-year findings from a sirolimus-eluting bioresorbable vascular scaffold (BVS) for the treatment of infrapopliteal lesions show great primary patency rates in lesions with an average lesion length of 3cm and a high rate of freedom from clinically-driven target lesion revascularisation.Dr Michel Bosiers (Inselspital Bern, Bern, CH) joins us to discuss the prospective, multicentre, single-arm,… View more

Vascular Disease and Surgery
Degradation Kinetics of Third Generation Resorbable Magnesium Scaffolds
Author(s): Michael Joner Added: 1 year ago
In this interview, ProfMichael Joner (German Heart Centre, DE)explains the resorption process of the new generation Resorbable Magnesium Scaffold and how the scaffold can have thinner struts and a resorption time of 12 months whilst having prolonged scaffolding time. View more

Intervention
A New Resorbable Magnesium Scaffold for de Novo Coronary Lesions
Author(s): Michael Haude Added: 1 year ago
In this interview, ProfMichael Haude (Rheinlandklinkum, DE) explains the DREAMS 3G device, what the BIOMAG-I study is and what impact this has on the data for the future of scaffolds. View more

Intervention
Vascular Access Management of Complex High Risk Interventional Procedures
Author(s): Jimmy Kerrigan , Timir K Paul , Jay Patel , et al Added: 1 year ago

Intervention

Vascular Disease and Surgery
12-months Vessel Healing Profile Following Novel Resorbable Magnesium Scaffold Implantation: An Intravascular OCT Analysis of the BIOMAG-I Trial
Author(s): Masaru Seguchi Added: 1 year ago
In this interview, Dr Masaru Seguchi (German Heart Centre, DE) explains the aim of the BIOMAG-I OCT analysis, what the findings were and what the data means for the future of cardiology. View more

Intervention
Future of Vascular Large Bore Closure and Best-in-Practice Management
Author(s): Darren Mylotte , Ole De Backer , Liesbeth Rosseel Added: 1 year ago
This breakout session hosted at Transcatheter Interventions Online 2024 is for interventional cardiologists keen on advancing their expertise in vascular closure techniques, with a special emphasis on large bore closures, the MultiCLOSE algorithm in TAVI procedures, and arterial and venous closures. Expert speakers, including Darren Mylotte, Ole De Backer and Liesbeth Rosseel, share insights and… View more

Intervention
LINC 25: The PATCH Study
Author(s): Sean Lyden Added: 5 months ago
LINC Conference 2025 - 30 day results of the PATCH study suggests the PerQSeal vascular closure device (Vivasure Medical Limited) can be used as an alternative percutaneous procedure for large-bore common femoral access, showing low risk of haematoma and a medium time of 0 minutes to achieve vessel closure.Dr Sean Lyden (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the PATCH single… View more

Vascular Disease and Surgery

Intervention
Comparison of Haemodynamic Responses to Landiolol Versus Esmolol
Author(s): Georgios Koukoulitsios , Kyriaki Tsikritsaki , Georgios Magklaras , et al Added: 1 month ago

Heart Failure

Vascular Disease and Surgery